BioUtah News

Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners…
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
Foldax Named Finalist in the Fierce Innovation Awards

Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020,…
Alucent Biomedical Announces $35 Million Series B Financing

Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is…
IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration

IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung…
SDP Oncology Announces New Data from Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase…
RenalytixAI Receives California Commercial Lab Certification

RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from…
The Point Kick Off

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning…
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the…
Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday…
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National…